CLINICAL_TRIALS
trial_result
· 2019-10-28
Clinical Trial Update: A Study to Compare Tivozanib (AV-951) to Sorafenib in Subjects With Advanced Renal Cell Carcinoma [Phase 3]
Summary
Phase 3 trial comparing tivozanib to sorafenib in advanced renal cell carcinoma has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AVEO Pharmaceuticals, Inc. | Conditions: Advanced Renal Cell Carcinoma | Phase 3 | Status: COMPLETED | Results posted: 2019-10-28